Skip to main content
Clinical Trials/CTRI/2020/02/023488
CTRI/2020/02/023488
Not yet recruiting
未知

A comparative study of efficacy and safety of Sacubitril/ Valsartan combination with Ramipril on left ventricular ejection fraction in post coronary artery bypass grafting (CABG) patients.

Soumitra Mandal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: I257- Atherosclerosis of coronary arterybypass graft(s) and coronary artery of transplanted heart with angina pectoris
Sponsor
Soumitra Mandal
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Soumitra Mandal

Eligibility Criteria

Inclusion Criteria

  • I.Patients planning for CABG
  • II.Age in between 30 to 70 years.
  • III.New York Heart association (NYHA) functional class II\-IV symptoms for heart failure.
  • IV.Ejection fraction of 40% or less.

Exclusion Criteria

  • I.Symptomatic hypotension (Systolic blood pressure \< 100 mm hg).
  • II.Estimated glomerular filtration rate \<30 ml/min/1\.73 m2 \[Gfr estimated by MDRD study equation]
  • III.Hypersensitivity to study medication.
  • IV.Any history of angioedema.
  • V.Concomitant use with any drug formulation containing an angiotensin\-converting enzyme inhibitor.

Outcomes

Primary Outcomes

Not specified

Similar Trials